Profile data is unavailable for this security.
About the company
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
- Revenue in USD (TTM)359.05bn
- Net income in USD3.30bn
- Incorporated1994
- Employees43.00k
- LocationMcKesson Corp6555 State Highway 161IRVING 75039United StatesUSA
- Phone+1 (972) 446-4800
- Fax+1 (302) 636-5454
- Websitehttps://www.mckesson.com/
Mergers & acquisitions
| Acquired company | MCK:NYQ since announced | Transaction value |
|---|---|---|
| PRISM Vision Holdings LLC | 18.30% | 850.00m |
| Community Oncology Revitalization Enterprise Ventures LLC | 28.51% | 2.49bn |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 11.25m | 8.98% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 6.57m | 5.24% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 5.69m | 4.54% |
| Massachusetts Financial Services Co.as of 31 Mar 2025 | 4.02m | 3.20% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2025 | 3.07m | 2.45% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2025 | 2.83m | 2.26% |
| Geode Capital Management LLCas of 31 Mar 2025 | 2.71m | 2.16% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 2.11m | 1.68% |
| Putnam Investment Management LLCas of 31 Mar 2025 | 1.89m | 1.51% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2025 | 1.55m | 1.24% |
